SCHEMBL4661373

SCHEMBL4661373

Cc1ccc(O)c([C@H](CC[N+](C)(C(C)C)C(C)C)c2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.62
CHRM1 P11229 4/20 0.62
MAPT P10636 4/20 0.62
CHRM2 P08172 3/20 0.62
CHRM3 P20309 3/20 0.62
CHRM5 P08912 2/20 0.62
HRH1 P35367 2/20 0.62
KCNH2 Q12809 2/20 0.62
ADRA1A P35348 2/20 0.62
ESR1 P03372 1/20 0.62
CHRM4 P08173 1/20 0.62
KCNE1 P15382 1/20 0.62
PTGS1 P23219 1/20 0.62
HRH2 P25021 1/20 0.62
HTR2A P28223 1/20 0.62
SLC6A4 P31645 1/20 0.62
OPRK1 P41145 1/20 0.62
KCNQ1 P51787 1/20 0.62
CACNA1C Q13936 1/20 0.62
SCN5A Q14524 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16887883 1.00 LMNA (0.62) LMNACHRM1MAPTCHRM2CHRM3
Hydrochloric Acid SCHEMBL4660997 0.99 LMNA (0.61) LMNACHRM1MAPTCHRM2CHRM3
Iodide SCHEMBL4661249 0.99 LMNA (0.61) LMNACHRM1MAPTCHRM2CHRM3
Bromide SCHEMBL4662300 0.99 LMNA (0.61) LMNACHRM1MAPTCHRM2CHRM3
SCHEMBL4662570 0.90 CHRM1 (0.48) LMNACHRM1MAPTCHRM2CHRM3
Tolterodine SCHEMBL6052412 0.90 CHRM3 (0.78) LMNACHRM1MAPTCHRM2CHRM3
SCHEMBL4662609 0.89 CHRM1 (0.49) LMNACHRM1MAPTCHRM2CHRM3
Iodide SCHEMBL4662550 0.89 CHRM1 (0.47) LMNACHRM1MAPTCHRM2CHRM3
SCHEMBL4663900 0.88 CHRM1 (0.49) LMNACHRM1MAPTCHRM2CHRM3
Iodide SCHEMBL4661363 0.88 CHRM1 (0.48) LMNACHRM1MAPTCHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461306-B1 QUATERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS PHARMACIA & UPJOHN CO LLC (US) 2008-12-24 EP claimed
EP-1461306-B1 QUATERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS PHARMACIA & UPJOHN CO LLC (US) 2008-12-24 EP disclosed
EP-1461306-B1 QUATERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS PHARMACIA & UPJOHN CO LLC (US) 2008-12-24 EP disclosed
US-7439397-B2 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis PFIZER INC (US) 2008-10-21 US disclosed
US-7439397-B2 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis PFIZER INC (US) 2008-10-21 US disclosed
EP-1461306-A1 QUATERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS PHARMACIA & UPJOHN COMPANY (US) 2004-09-29 EP disclosed
WO-2003035599-A1 QUARTERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-05-01 WO disclosed